In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis
Aggarwal A, Jang S, Vardhan S, Webber F, Alam M, Vardhan M, Lancaster G, Ahmad Y, Vora A, Zarich S, Inglessis-Azuaje I, Elmariah S, Forrest J, Davila C. In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis. Structural Heart 2024, 100327. DOI: 10.1016/j.shj.2024.100327.Peer-Reviewed Original ResearchSurgical aortic valve replacementTranscatheter aortic valve replacementAortic valve replacementTranscatheter aortic valve replacement groupValve replacementIn-hospital mortalityHepatorenal syndromeReadmission ratesCardiogenic shockLiver cirrhosisVascular complicationsIn-hospitalOutcomes of transcatheter aortic valve replacementSurgical risk prediction modelsSurgical aortic valve replacement groupAssociated with significantly lower ratesRates of in-hospital mortalityLimited contemporary dataIn-hospital outcomesSignificantly lower ratesNationwide Readmissions DatabaseCardiac surgeryPeriprocedural morbidityTherapeutic optionsClinical characteristicsCatecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies
Aggarwal A, Stolear A, Alam M, Vardhan S, Dulgher M, Jang S, Zarich S. Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies. Journal Of Clinical Medicine 2024, 13: 1781. PMID: 38542006, PMCID: PMC10971616, DOI: 10.3390/jcm13061781.Peer-Reviewed Original ResearchCatecholaminergic polymorphic ventricular tachycardiaLeft cardiac sympathetic denervationTraditional first-line treatmentAbsence of structural heart diseaseCalsequestrin 2 geneMyocyte sarcoplasmic reticulumRate of arrhythmic eventsCardiac ryanodine receptorCardiac sympathetic denervationPolymorphic ventricular arrhythmiasFirst-line treatmentPolymorphic ventricular tachycardiaStructural heart diseaseB-blocker therapySudden cardiac deathPotential new therapiesExercise stress testImplantable cardioverter-defibrillatorHereditary arrhythmia syndromesArrhythmia syndromesRyanodine receptorSarcoplasmic reticulumModerate exercise trainingSympathetic denervationArrhythmic events